Its announcement comes about the heels of the same licensing arrangement available in February to Adastra Labs, which experienced until finally now focused on crafting cannabis extracts. Adastra's license also makes it possible for it to generate and provide psilocybin and psilocin – hallucinogens far more generally known as magic mushrooms that